Assistant Professor, Pediatrics, University of North Carolina at Chapel Hill School of Medicine
Pediatric Gastroenterology
Dr. Michael Kappelman, MD
|
|
Give Review
Michael Kappelman works in the field of Pediatric Gastroenterology. He studied medicine at Washington University School of Medicine in St. Louis. Michael Kappelman, MD is a published doctor and has 74 publications published. The lastest was: 'Comparative effectiveness and safety of infliximab and adalimumab in patients with ulcerative colitis.' He is registered with Medicare and accepts Medicare payments.
Publications
- Comparative effectiveness and safety of infliximab and adalimumab in patients with ulcerative colitis.
- O-021 A New Domain Structure for the IMPACT-III, a Pediatric Inflammatory Bowel Disease (IBD) Health Reported Quality of Life (HRQOL) Tool.
- Role of Nonsteroidal Anti-Inflammatory Drugs in Exacerbations of Inflammatory Bowel Disease.
- Immunosuppression for management of Crohn's disease.
- Harnessing person-generated health data to accelerate patient-centered outcomes research: the Crohn's and Colitis Foundation of America PCORnet Patient Powered Researc...
- Characterization of Genetic Loci That Affect Susceptibility to Inflammatory Bowel Diseases in African Americans.
- Racial disparities in readmission, complications, and procedures in children with Crohn's disease.
- Prevalence of chronic narcotic use among children with inflammatory bowel disease.
- Exercise Decreases Risk of Future Active Disease in Patients with Inflammatory Bowel Disease in Remission.
- Perceptions of patients with inflammatory bowel diseases on biobanking.
- Health-Care Utilization, Costs, and the Burden of Disease Related to Eosinophilic Esophagitis in the United States.
- Feasibility and Validity of the Pediatric Ulcerative Colitis Activity Index in Routine Clinical Practice.
- Retrospective cohort study of methotrexate use in the treatment of pediatric Crohn's disease.
- Prevalence of a Gluten-free Diet and Improvement of Clinical Symptoms in Patients with Inflammatory Bowel Diseases.
- Effectiveness of Anti-TNFα for Crohn Disease: Research in a Pediatric Learning Health System.
- Appropriateness of Emergency Department Use in Pediatric Inflammatory Bowel Disease: A Quality Improvement Opportunity.
- Liver Enzyme Elevations within Three Months of Diagnosis of Inflammatory Bowel Disease and Likelihood of Liver Disease.
- Seasonality and Pediatric Inflammatory Bowel Disease: A Multicenter Experience.
- Validation of an Internet-Based Cohort of Inflammatory Bowel Disease (CCFA Partners).
- Topiramate Use Does Not Reduce Flares of Inflammatory Bowel Disease.
- Implementable Strategies and Exploratory Considerations to Reduce Costs Associated with Anti-TNF Therapy in Inflammatory Bowel Disease.
- The burden of comedication among patients with inflammatory bowel disease.
- Immunization Rates and Vaccine Beliefs Among Patients with Inflammatory Bowel Disease: An Opportunity for Improvement.
- Challenges in Designing a National Surveillance Program for Inflammatory Bowel Disease in the United States.
- Evaluation of the Patient Reported Outcomes Measurement Information System in a large cohort of patients with Inflammatory Bowel Diseases.
- The Prevalence of Eosinophilic Esophagitis in the United States.
- Risk factors for depression in the elderly inflammatory bowel disease population.
- Dietary patterns and self-reported associations of diet with symptoms of inflammatory bowel disease.
- Risk of Cancer in Patients with Inflammatory Bowel Diseases: a Nationwide Population-Based Cohort Study with 30 Years of Follow Up.
- Patient Perception of Chronic Illness Care in a Large Inflammatory Bowel Disease Cohort.
- Incidence, Clinical Characteristics, and Natural History of Pediatric IBD in Wisconsin: a Population-based Epidemiological Study.
- Challenges in IBD Research: Update on Progress and Prioritization of the CCFA's Research Agenda.
- Quality Indicators for Inflammatory Bowel Disease: Development of Process and Outcome Measures.
- Early Life Exposures as Risk Factors Forpediatric Eosinophilic Esophagitis: A Pilot and Feasibility Study.
- Increased risk of pneumocystis jiroveci pneumonia among patients with inflammatory bowel disease.
- Environmental factors and inflammatory bowel disease: elusive or nonexistent?
- Surveillance for Hepatocellular Carcinoma in a Medicaid Cirrhotic Population.
- Increased risk of pneumonia among patients with inflammatory bowel disease.
- Recent Trends in the Prevalence of Crohn's Disease and Ulcerative Colitis in a Commercially Insured US Population.
- Sleep Disturbance and Risk of Active Disease in Patients with Crohn's Disease and Ulcerative Colitis.
- Increased risk of Herpes zoster among 108 604 patients with inflammatory bowel disease.
- Burden of Gastrointestinal Disease in the United States: 2012 Update.
- Risk of Melanoma and Non-Melanoma Skin Cancer among Patients with Inflammatory Bowel Disease.
- Impact of the 2008-2009 Economic Recession on Screening Colonoscopy Utilization Among the Insured.
- Association of paediatric inflammatory bowel disease with other immune-mediated diseases.
- Statins are associated with reduced use of steroids in inflammatory bowel disease: A retrospective cohort study.
- Quality of care for gastrointestinal conditions: a primer for gastroenterologists.
- Nonmelanoma skin cancer in inflammatory bowel disease: A review.
- Risk of diagnosed fractures in children with inflammatory bowel diseases.
- Outcome following thiopurine use in children with ulcerative colitis: a prospective multicenter registry study.
- Response to thakrar.
- Development of process and outcome measures for improvement: Lessons learned in a quality improvement collaborative for pediatric inflammatory bowel disease.
- Thiazolidinedione use and ulcerative colitis-related flares: an exploratory analysis of administrative data.
- Thromboembolic risk among Danish children and adults with inflammatory bowel diseases: a population-based nationwide study.
- Short pediatric Crohn's disease activity index for quality improvement and observational research.
- Utilization of healthcare resources by U.S. children and adults with inflammatory bowel disease.
- ImproveCareNow: The development of a pediatric inflammatory bowel disease improvement network.
- Isotretinoin use and the risk of inflammatory bowel disease: a case-control study.
- Factors that determine risk for surgery in pediatric patients with Crohn's disease.
- Increased risk for non-melanoma skin cancer in patients with inflammatory bowel disease.
- Quality of care in inflammatory bowel disease: a review and discussion.
- Diagnostic ionizing radiation exposure in a population-based sample of children with inflammatory bowel diseases.
- A causal association between isotretinoin and inflammatory bowel disease has yet to be established.
- Quality of health care in the United States: implications for pediatric inflammatory bowel disease.
- Suboptimal rates of cervical testing among women with inflammatory bowel disease.
- Direct health care costs of Crohn's disease and ulcerative colitis in US children and adults.
- Does inflammatory bowel disease develop in infants?
- The prevalence and geographic distribution of Crohn's disease and ulcerative colitis in the United States.
- Intercenter variation in initial management of children with Crohn's disease.
- Primary ciliary dyskinesia as a cause of neonatal respiratory distress: implications for the neonatologist.
- Nutritional concerns in pediatric inflammatory bowel disease patients.
- Prevalence and epidemiology of overweight and obesity in children with inflammatory bowel disease.
- Patterns of 6-mercaptopurine and azathioprine maintenance therapy among a cohort of commercially insured individuals diagnosed with Crohn's disease in the United States.
Schools
Washington University School Of Medicine
Providence Hospital
Providence Medical Center
Doctors Specialties
- Family Medicine
- Geriatric Medicine
- Pediatric Gastroenterology
Accepted Insurances
- Accepts most major Health Plans. Please contact our office for details.
- Special Needs Plan SNP
- Medicare MCR
Education
-
Boston Children's Hospital -
Massachusetts General Hospital -
Washington University School of Medicine in St. Louis
Drug Facts
| NPI NUMBER | 1912941907 | |
| NPPES Provider LastName | KAPPELMAN | |
| NPPES Provider FirstName | MICHAEL | |
| NPPES Provider ZIPCode | 980706584 | |
| NPPES Provider State | WA | |
| Specialty Description | Family Practice | |
| Total Claim Count | 3988.0 | |
| Distinct Opioid Count | 2.0 | |
| Opioid Claim Count | 65.0 | |
| Percent Opioid Claims | 1.63 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1912941907 |
| Last Name Of The Provider | KAPPELMAN |
| First Name Of The Provider | MICHAEL |
| View All |
Similar Doctors
|
Dr. Jeffrey Hanspetersen, MD |
|
|
Dr. Chad R. Magnuson, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Laurel Kuehl, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sjardo S. Steneker, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Charles G. Weispfenning, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Bisher A. Abdullah, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joseph D. Gramling, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Catherine M. Konrad, ARNP
This Doctor is OpenDoctor Recommended.
|